Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

Clinical progressive disease (cPD) occurs during neoadjuvant chemotherapy (NAC) in 3%–5% of triple‐negative breast cancer (TNBC) patients. We aimed to identify the histopathological and immunohistochemical parameters that are correlated with the TNBC that showed cPD. We identified 22 TNBCs that show...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Tanabe, Yuko, Tsuda, Hitoshi, Yoshida, Masayuki, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Yamamoto, Seiichiro, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tamura, Kenji
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5497804/
https://ncbi.nlm.nih.gov/pubmed/28474753
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados